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hancer factor-1 (LEF-1) family of transcription factors.senilin functions as a scaffold that rapidly couples
The importance of maintaining rapid proteolysis of-catenin phosphorylation through two sequential ki-
-catenin is manifested by the oncogenic activation ofnase activities independent of the Wnt-regulated Axin/
-catenin signaling either by direct mutation of -cate-CK1 complex. Thus, presenilin deficiency results in
nin or by inactivation of APC or Axin (reviewed by Po-increased -catenin stability in vitro and in vivo by
lakis, 2000).disconnecting the stepwise phosphorylation of -cate-
Increasing evidence supports the concept that PS1nin, both in the presence and absence of Wnt stimula-
is an important negative regulator of -catenin. In ation. These findings highlight an aspect of -catenin
genetic screen, the Drosophila presenilin (DPS) wasregulation outside of the canonical Wnt-regulated path-
identified as a negative modifier of wingless/Wnt signal-way and a function of presenilin separate from intra-
ing (Cox et al., 2000), and DPS deficiency resulted inmembrane proteolysis.
cytoplasmic accumulation of armadillo/-catenin (Noll
et al., 2000). Our own studies showed that PS1 defi-
Introduction ciency in primary fibroblasts leads to stabilization of free
-catenin, possibly at a step between phosphorylation
Mutations in two homologous genes, presenilin 1 (PS1) and ubiquitination of -catenin (Soriano et al., 2001). In
and presenilin 2 (PS2), are the major causes of early- agreement with this finding, loss of PS1 was associated
onset familial Alzheimer’s disease (FAD) (Sherrington with elevated cyclin D1 transcription and accelerated
et al., 1995; Rogaev et al., 1995). The presenilins are proliferation in cultured cells, as well as epidermal hy-
polytopic proteins with six to eight transmembrane do- perplasias and tumors in vivo in an animal model of PS1
mains containing a large hydrophilic cytoplasmic loop deficiency (Xia et al., 2001).
domain that is present in high-molecular-weight com- Despite these observations, the mechanism by which
plexes (Doan et al., 1996; Yu et al., 1998). presenilin presenilin negatively regulates -catenin stability and
mutations associated with FAD selectively elevate the signaling is unknown. The canonical model of Wnt-regu-
pathogenic 42 amino acid amyloid -peptide (A42). lated -catenin signaling revolves around the regulation
In addition, presenilins are required for the regulated of -catenin phosphorylation at S45 followed by Thr41,
intramembrane proteolysis (RIP) of the amyloid precur- Ser37, and Ser33 (Yost et al., 1996; Liu et al., 2002).
sor protein (APP) and the Notch receptors such that Based on our earlier studies (Kang et al., 1999; Soriano
presenilin deficiency abrogates A generation and Notch et al., 2001), we hypothesized that PS1 might be involved
in regulating these multiple phosphorylation events.
Here, we show that presenilin contributes to -catenin5 Correspondence: edkoo@ucsd.edu
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degradation by facilitating the stepwise phosphorylation
of -catenin independently of the Wnt-controlled Axin
complex.
Results
presenilin Deficiency Selectively Reduces
Turnover of S45 Phosphorylated -Catenin
We previously reported that PS1 deficiency resulted in
elevated cytosolic -catenin levels together with higher
steady-state levels of total phosphorylated -catenin,
suggesting that PS1 might be involved in targeting phos-
phorylated -catenin for degradation (Soriano et al.,
2001). This prompted us to investigate the role of pre-
senilin in modulating the turnover of distinct phosphory-
lated species of -catenin with antibodies specifically
recognizing either S45-phosphorylated -catenin (P-45)
or that phosphorylated at positions 33, 37, and 41 (P-33/
37/41) The characterization of phospho-specific -cate-
nin antibodies, response of phospho--catenin to Wnt
signaling, and immunolocalization of phosphorylated
-catenin species are documented in the Supplemental Figure 1. Selective Impairment in P-45 -Catenin Turnover in the
Absence of presenilinData (see Supplemental Figures S1 and S2 at http://
www.cell.com/cgi/content/full/110/6/751/DC1). Consis- (A) Accumulation of P-45 parallels the reduction in P-33/37/41
-catenin in PS/ cells. Equal protein amounts from confluent cul-tent with a recent report (Liu et al., 2002), we observed
tures of PS/ and PS/ (PS1/; PS2/) cells were immunoblottedthat Wnt signaling rapidly decreased the steady-state
for total, P-45, and P-33/37/41 -catenin epitopes, as well as tubulinlevels of P-33/37/41 but not P-45 -catenin, resulting
and Axin.
in accumulation of cytosolic -catenin (Supplemental (B) Phospho-41/45 antibody detects only P-45 -catenin from cell
Figure S1B). In addition, cotransfection of -catenin with lysates. The phospho-41/45 antibody was preincubated with either
the P-45, P-41, or P-33/37/41 phospho-peptides and immunoblottedLEF-1 led to nuclear localization of P-45 but not P-33/
against equal protein amounts from PS/ and PS/ cells.37/41 -catenin (Supplemental Figure S1C), indicating
(C) Selective impairment in turnover of P-45 but not P-33/37/41the S45-phosphorylated -catenin is signaling compe-
-catenin in the absence of presenilin. Confluent cultures of PS/tent. To exclude the possibility that PS2 might compen-
and PS/ cells were treated with cycloheximide (CHX) for the indi-
sate for PS1 deficiency, fibroblasts genetically deficient cated time periods and immunoblotted for P-45 or P-33/37/41
in both PS1 and PS2 (PS/) and corresponding wild- -catenin. Immunoblot exposures were adjusted to show similar
signal at time 0.type controls (PS/) were examined. In PS/ fibro-
blasts, P-45 -catenin was elevated almost 3-fold (2.7
1.18, SD n  5) as compared to PS/ control cells
(Figure 1A), comparable to an average 2.5-fold increase ano et al., 2001) in PS/ cells reversed the impairment
in the turnover of P-45 -catenin (see Supplemental(1.21, SD n  5) in total CHAPS-extracted -catenin.
In contrast, the level of P-33/37/41 -catenin in PS/ Figures S2A and S2B at http://www.cell.com/cgi/content/
full/110/6/751/DC1). Notably, the D257A mutant of PS1cells was reduced to 62% 13% (n 5) of PS/ levels
(Figure 1A). Thus, the ratio of P-33/37/41 per P-45 that impairs Notch proteolysis contained full activity in
restoring P-45 -catenin turnover (Supplemental Figure-catenin was reduced almost 5-fold, to 22%  9%
(n  5) of PS/ control. The changes detected by the S2B). Furthermore, a -secreatase inhibitor that inhibits
both APP and Notch cleavages had no effect on P-45phospho-41/45 antibody was attributable solely to S45-
phosphorylated -catenin, as preabsorption with phos- turnover in either PS/ or PS/ cells (Supplemental
Figure S2C), indicating that intramembrane proteolysispho-45 peptide alone but not phospho-41 or phospho-
33/37/41 peptides eliminated all immunoreactivity in and-catenin turnover are two mutually exclusive activi-
ties of presenilin. Unlike in PS/ cells, a truncating APCPS/ and PS/ cell lysates (Figure 1B). No differences
in Axin protein levels were detected between PS/ and mutation or a S37F -catenin mutation resulted in stabili-
zation of both phosphorylated species of -catenin (Sup-PS/ cells (Figure 1A).
To determine whether the elevation of S45 phosphory- plemental Figure S3), indicating mechanistically distinct
defects. These results demonstrate that presenilin defi-lated -catenin in presenilin-deficient cells was due to
impaired turnover, -catenin levels were assessed after ciency leads to a unique imbalance of phosphorylated
-catenin species, possibly by impairing the stepwisecycloheximide (CHX) treatment. In PS/ cells, the turn-
over of P-45 (t1/2  25 min) and P-33/37/41 (t1/2  15 min) phosphorylation from S45 to 33/37/41 positions.
epitopes was rapid (Figure 1C). In contrast, the turnover
of P-45 -catenin but not P-33/37/41 -catenin was im- Reduced -Catenin Substrate for Ubiquitin
Conjugation by the Loss of presenilinpaired in PS/ cells with a half-life of 	120 min for
the species phosphorylated at S45 (Figure 1C). Stable Following phosphorylation, -catenin is ubiquitinated
and rapidly degraded by the ubiquitin-proteasome ma-transfection of wild-type PS1 but not a deletion mutant
incapable of associating with -catenin (PS1 
cat; Sori- chinery (Aberle et al., 1997; Ikeda et al., 1998). We found
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Figure 2. Ubiquitin Conjugation of -Catenin
Reduced by the Loss of presenilin
(A) Specific detection of high-molecular-
weight multiubiquitin conjugates on P-33/37/
41 but not on P-45 -catenin. HEK 293 cells
were treated with the proteasome inhibitor
MG-132 for the indicated time periods, immu-
noprecipitated for total -catenin (IP -cat)
or multiubiquitin (IP ubiquitin), and immu-
noblotted for P-45 or P-33/37/41 -catenin.
(B) Reduced P-33/37/41 -catenin substrate
for ubiquitin conjugation in the absence of
presenilin. Confluent cultures of PS/ and
PS/ cells were treated with proteasome in-
hibitor MG-132 for the indicated time periods
and immunoblotted for P-45 -catenin. In
parallel, lysates were immunoprecipitated for
multiubiquitin prior to immunoblotting for
P-33/37/41 -catenin.
that treatment of PS/ or HEK 293 cells with the protea- by incorporation of [32P]ATP. Indeed, PS1 immunoprecipi-
tates phosphorylated recombinant -catenin in vitro, butsome inhibitor MG-132 resulted in the accumulation of
both P-33/37/41 and P-45-catenin, indicating that both such activity was absent from PS/ cells (Figure 3A).
We next asked whether the PS1 complex containsphosphorylated -catenin species are targeted for deg-
radation by the proteasome (Figures 2A and 2B). How- kinase activities capable of specifically phosphorylating
S45 and/or residues 33/37/41. Surprisingly, PS1 immuneever, the accumulation of high-molecular-weight spe-
cies of P-33/37/41 was dramatically greater than that complex phosphorylated S45 in both recombinant-cate-
nin and endogenous -catenin that coprecipitated withseen with P-45 -catenin species (Figure 2A). These
higher molecular weight species were indeed ubiquiti- PS1 (Figure 3B). The S45 phosphorylation event was
not mediated by GSK-3 since this activity was LiClnated, since multiubiquitin immune complexes con-
tained large amounts of slower migrating P-33/37/41 insensitive, and purified GSK-3was incapable of phos-
phorylating recombinant -catenin at this position (Fig--catenin (Figures 2A and 2B) but not P-45 -catenin
(data not shown). ures 3B, 3C, and 3F). To ascertain that S45 phosphoryla-
tion of -catenin was not an in vitro artifact of the PS1In PS/ cells, the time-dependent accumulation of
P-45 but not P-33/37/41 -catenin species was absent immune complex, we cotransfected either Axin or PS1
together with a mutant -catenin (33A37A-HA) that canup to 60 min of MG-132 treatment (Figure 2B), consistent
with the impairment in P-45-catenin turnover. Although be phosphorylated on S45, but incapable of further
phosphorylation at positions 33/37/41 in HEK 293T cells.the initial increase in P-33/37/41 multiubiquitinated spe-
cies in PS/ cells was identical to PS/ cells, there As seen in this experiment, overexpression of either PS1
or Axin supported increased S45 -catenin phosphory-was no further increase between 15 and 60 min (Figure
2B). This indicated that presenilin deficiency reduces lation in cultured cells (see Supplemental Figure S4A at
http://www.cell.com/cgi/content/full/110/6/751/DC1).the pool of P-33/37/41 substrate available for ubiquitina-
tion by failing to target P-45 for further phosphorylation Consistent with the above data and the priming model
of -catenin phosphorylation, PS1 immune complexand degradation, thereby accounting for the selective
accumulation of P-45 -catenin in PS/ cells. contained an activity that strongly increased the ability
of GSK-3 to phosphorylate -catenin on residues 33/
37/41 in a time-dependent manner (Figures 3C and 3D),Presenilin Couples S45 Phosphorylation to GSK-
3 Activity on Residues 33/37/41 of -Catenin even though neither Axin nor CK1 could be detected
in the PS1 complex (data not shown). In the latter experi-The efficient phosphorylation of many substrates (e.g.,
glycogen synthase) by GSK-3 is dependent on a prior ment, PS1 immune complex was capable of phosphory-
lating -catenin in the absence of exogenous GSK-3,or “priming” phosphorylation 4 residues C terminal to
the GSK-3 site by another protein kinase (Fiol et al., even though there was far less endogenous GSK-3 in
the PS1 complex compared to the amount of purified1990). This priming event has similarly been suggested
for -catenin (Dajani et al., 2001; Pai et al., 1997) and GSK-3 added to the reaction (Figure 3D). Thus, these
results demonstrate that PS1 strongly promotes GSK-elegantly confirmed by the demonstration that the Axin
complex sequesters CK1 as a S45 priming kinase for 3-dependent sequential phosphorylation of Thr41,
Ser37, and Ser33, starting presumably from a GSK-subsequent phosphorylation by GSK-3 (Liu et al., 2002).
Since presenilin appeared to function as an intermediate 3-independent priming event on S45.
between S45 and 33/37/41 phosphorylation, we next
asked whether PS1-associated components are capa- Protein Kinase A Pathway in Presenilin-Mediated
S45 -Catenin Phosphorylationble of mediating the phosphorylation of -catenin in
vitro. We first examined PS1 immune complexes from We have previously documented the complex formation
of PS1 with both -catenin and GSK-3 (Kang et al.,PS/ (hPS1), PS/, or PS/ (hPS1) cells for activity
capable of phosphorylating recombinant GST--catenin 1999). However, since S45 phosphorylation was not me-
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Figure 3. Presenilin Complex Couples Prim-
ing Phosphorylation on S45 to GSK-3 Activ-
ity on Residues 33/37/41 of -Catenin
(A) Phosphorylation of recombinant GST-
-catenin by the PS1 complex. Equal protein
amount from confluent cultures of PS/,
PS/ (hPS1), or PS/ (hPS1) cells were im-
munoprecipitated with J27 for PS1 or with
J27 preimmune serum (pre), incubated with
purified GST--catenin in the presence of
[-32P]ATP, and fractionated by SDS-PAGE,
and dried gels were exposed to film.
(B) Specific phosphorylation on S45 of
-catenin by the PS1 complex. Lysates from
confluent cultures of PS/ (hPS1) cells were
immunoprecipitated for PS1 (PS complex), in-
cubated with or without purified GST-
-catenin in kinase buffer containing 25 mM
LiCl for 30 min, and immunoblotted for P-45
-catenin. For analysis of GSK-3 activity,
purified GSK-3 (2.5U) was included in the
reaction in the absence of LiCl.
(C) PS1 complex facilitates GSK-3-depen-
dent phosphorylation of -catenin on res-
idues 33/37/41. Lysates from confluent cul-
tures of PS/ (hPS1) cells were immunopre-
cipitated for PS1 (PS complex), incubated
with or without purified GST--catenin and
GSK-3 (2.5U) in kinase buffer for 30 min, and
immunoblotted for P-33/37/41 -catenin.
(D) Endogenous PS1 complex phosphory-
lates -catenin on residues 33/37/41. Lysates
from confluent cultures of PS/ (hPS1) cells
were immunoprecipitated for PS1 (PS com-
plex), incubated with or without and GSK-3
(2.5 U) together with purified GST--catenin
in kinase buffer for the indicated times, and
immunoblotted for P-33/37/41 -catenin. Note the presence of coprecipitated GSK-3 in PS1 complex directly below IgGs (double asterisk).
(E) PKA pathway enhances the S45 phosphorylation of -catenin in the PS1 complex. Confluent PS/ (hPS1) cells were pretreated with or
without forskolin (5 M) for 45 min prior to lysis, and PS1 immunoprecipitates (PS complex) or beads alone were incubated with purified GST-
-catenin in kinase buffer for 30 min and immunoblotted for P-45 -catenin and catalytic subunit of PKA.
(F) Prior phosphorylation on S45 by PKA primes GSK-3-dependent phosphorylation on residues 33/37/41 of -catenin. Purified catalytic
subunit of PKA (10 U) was preincubated with GST--catenin in kinase buffer for 30 min. Then PKA inhibitor H-89 (2 M) plus purified GSK-
3 (2 or 20 U) or H-89 (2 M) alone was subsequently added to the PKA reaction for an additional 30 min. In parallel, purified GSK-3 (2 or
20 U) plus H-89 (2 M) was incubated with GST--catenin in kinase buffer for 30 min. The reactions were then subjected to immunoblotting
for P-45 and P-33/37/41 -catenin.
diated by GSK-3, we hypothesized that PS1 functions contained markedly higher S45 kinase activity on recom-
binant -catenin but also a larger amount of the catalyticto bring together not only -catenin and GSK-3but also
a priming kinase that phosphorylates S45 of -catenin. subunit of PKA (Figure 3E), indicating that PKA might
serve as a priming kinase in the PS1 complex. Indeed,Since neither Axin nor CK1 could be detected in PS1
immune complexes, we tested the potential impact of purified PKA robustly phosphorylated recombinant -cate-
nin on S45 but had no activity on residues 33/37/41two candidate kinase pathways previously shown to
phosphorylate PS1 and protein kinase C (PKC) and A (Figure 3F). GSK-3 alone phosphorylated recombinant
-catenin at residues 33/37/41 poorly (Figure 3F). How-(PKA) on S45 phosphorylation of -catenin (Seeger et
al., 1997; Walter et al., 1998). In HEK 293 cells, activation ever, prior phosphorylation of S45 by PKA strongly en-
hanced GSK-3-dependent phosphorylation of -cate-or inhibition of the PKC pathway had no effect on the
levels of the P-45 -catenin (data not shown). In con- nin at residues 33/37/41 (Figure 3F), in accordance with
the priming kinase model of -catenin phosphorylation.trast, activation of PKA pathway by forskolin robustly
elevated P-45 levels (see Supplemental Figure S5A at Such priming kinase activity of PKA has previously been
demonstrated in CREB and recently in Cubitus inter-http://www.cell.com/cgi/content/full/110/6/751/DC1).
Thus, we asked whether the PKA pathway might repre- ruptus (Fiol et al., 1994; Price and Kalderon, 2002). Inhibi-
tion of either CK1 or PKA, two putative priming kinasesent a S45 kinase activity within the PS1 complex. For
this purpose, PS/ (hPS1) cells were pretreated with pathways, not only reduced S45 phosphorylation but
also the subsequent phosphorylation at 33/37/41 inor without forskolin to activate PKA, and PS1 immune
complexes were examined for S45 kinase activity on PS/ cells (Supplemental Figure S5B). Taken together,
the aforementioned results indicate that while presenilinrecombinant GST--catenin. Surprisingly, PS1 immune
complexes isolated after forskolin treatment not only is not required for S45 phosphorylation, the presenilin/
Presenilin-Dependent -Catenin Degradation
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Figure 4. Presenilin Functions Indepen-
dently of Wnt-Regulated Axin/CK1Complex
(A) Delayed recovery of -catenin phosphory-
lation and ubiquitination following Wnt expo-
sure by the loss of presenilin. PS/ and PS/
cells were treated with or without W3a CM
for 1 hr and replaced with normal medium
plus 10 M lactacystin (NML) for 1 and 2
hr, and cell lysates were immunoblotted for
P-45 (top) or immunoprecipitated for multiu-
biquitin followed by immunoblotting for P-33/
37/41 -catenin (bottom). Immunoblot expo-
sures were adjusted to show comparable sig-
nal without W3a CM.
(B) PS1 overexpression in Axin-deficient
SNU475 cells reduces -catenin levels. Equal
protein amounts from confluent cultures of
parental SNU475 cells, and those stably
transfected with PS1 [SNU475 (PS1)] were
immunoblotted for -catenin and PS1.
(C) Depletion of CK1 by RNAi. Sense RNA
or CK1 RNAi duplex was transfected in
PS/ and PS/ cells for 48 hr, and cell ly-
sates were immunoblotted for CK1 protein.
(D) Additive effects of CK1 depletion and
presenilin deficiency on S45 phosphorylation of -catenin. PS/ and PS/ cells were subjected to sense RNA or CK1 RNAi for 48 hr with
or without lactacystin (10 M) for 90 min prior to cell lysis and were immunoblotted for P-45 -catenin. Note the equal reduction in P-45 in
both PS/ and PS/ cells, but increase in P-45 -catenin by lactacystin treatment after CK1 RNAi only in PS/ cells. Immunoblot exposures
were adjusted to show similar signal without RNAi.
PKA pathway functions to connect the priming phos- -catenin to baseline levels in PS1/ cells following
transient W3a exposure (Soriano et al., 2001). Becausephorylation at S45 to GSK-3-dependent phosphoryla-
Wnt inactivates the Axin complex, we next askedtion at residues 33/37/41 of -catenin.
whether presenilin activity is retained during exposure
to Wnt stimulation. W3a CM reduced the amount ofPresenilin Functions Independently
P-33/37/41 -catenin without altering P-45 levels in HEKof the Wnt-Regulated Axin Complex
293 cells. However, overexpression of PS1 prior to W3aWnt signaling is not only critical during embryogenesis
CM treatment led to an increase in P-45 and restorationbut also in adult tissue. Thus, inappropriate control of
of P-33/37/41 levels (see Supplemental Figure S4B atWnt signaling may result in cellular hyperplasia that may
http://www.cell.com/cgi/content/full/110/6/751/DC1),eventually progress to neoplasia. Because Wnt signaling
indicating that Wnt does not inactivate presenilin. Takennot only inactivates Axin but also induces its degrada-
together, these results suggest that presenilin activitytion (Ikeda et al., 1998; Yamamoto et al., 1999; Amit et
on -catenin phosphorylation is constitutive and notal., 2002), loss of Axin activity leads to sustained Wnt
modulated by the Wnt-Axin pathway, resulting in ele-signaling beyond the activity of the cell-surface ligand.
vated -catenin levels both constitutively and also afterTo determine whether presenilin is normally involved in
Wnt signaling by the loss of presenilin.timely restoration of -catenin degradation upon tran-
To further examine the relationship between presenilinsient exposure of Wnt signaling, we examined the recov-
and the Axin complex in -catenin turnover, SNU475
ery of -catenin phosphorylation and ubiquitin conjuga-
tumor cell line that lacks Axin and contains elevated
tion following withdrawal of Wnt-3a conditioned medium levels of -catenin was examined (Satoh et al., 2000).
(W3a CM) in PS/ and PS/ cell lines. Both PS/ and Axin cannot be stably expressed in SNU475 cells be-
PS/ cells are equally responsive to W3a CM, as seen cause of increased cell death as previously reported
by the reduction in P-33/37/41 -catenin species (data (Satoh et al., 2000), most likely through activation of the
not shown) and in the levels of cytosolic -catenin (Sori- proapoptotic JNK kinase pathway. Stable transfection
ano et al., 2001). After the cells were incubated with of PS1 in SNU475 cells, however, was possible and
W3a CM, the medium was replaced with normal culture resulted in greater than 2-fold reduction in total CHAPS-
medium together with lactacystin for 1 or 2 hr to block extractable -catenin (Figure 4B). Furthermore, PS1 ex-
proteasome function. In PS/ cells, there was a rapid pression elevated the ratio of P-33/37/41 to total
rise in the levels of both P-45 and ubiquitin-conjugated -catenin by2.5-fold relative to untransfected SNU475
P-33/37/41 -catenin species (Figure 4A). In contrast, cells (data not shown). Thus, the Axin complex is not
the increase in P-45 and ubiquitin-conjugated P-33/37/ necessary for the activity of PS1 on -catenin phosphor-
41 -catenin species was delayed in PS/ cells (Figure ylation/degradation.
4A), indicating that the loss of presenilin not only stabi-
lizes -catenin at steady-state but also following expo- Presenilin and Axin/CK1-Dependent Control
sure to Wnt by impairing the step-wise phosphorylation of -Catenin Degradation Are Additive
process. This observation is consistent with our previ- Because our results demonstrated that presenilin can
function independently of the Axin complex, we hypoth-ous data documenting the delay of restoring cytosolic
Cell
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esized that silencing CK1 expression, the priming ki- P-45 -catenin immunoreactivity were seen (Figure 5A).
In contrast, P-33/37/41 -catenin immunoreactivity wasnase on the Axin complex, should largely eliminate
-catenin turnover in PS/ cells but remain partially largely confined to the cytoplasm in both normal and
abnormal epidermis (Figure 5A). These findings led usintact in PS/ cells. Thus, RNA-mediated interference
(RNAi) of CK1 was applied for 48 hr with or without to hypothesize that loss of PS1 significantly contributes
to epidermal hyperproliferation by severing the link be-proteasome inhibition by lactacystin for 90 min before
lysis to determine the extent of phosphorylation and tween S45 and 33/37/41 -catenin phosphorylation/
degradation.turnover of -catenin. As previously shown in HEK 293T
cells (Liu et al., 2002), treatment with CK1RNAi reduced Our model that nuclear accumulation of P-45 stems
from disconnecting the paired phosphorylation of -cate-CKI protein levels by 70% (Figure 4C). This was ac-
companied by a substantial decrease in P-45 -catenin nin predicts that nuclear P-45 localization would also occur
in other in vivo settings where a similar disruption is knownlevels equally in both PS/ and PS/ cells (Figure 4D),
indicating that CK1 activity on S45 phosphorylation to be present. To test this prediction, we examined four
human medulloblastomas containing -catenin muta-is independent of presenilin. Nevertheless, proteasome
inhibition resulted in accumulation of P-45 -catenin tions that allow S45 phosphorylation but incomplete
subsequent phosphorylation and ubiquitination (D32A,both in the presence and absence of CK1RNAi in PS/
cells (Figure 4D, lanes 4 and 5). In marked contrast, S33F, or D32Y) and four medulloblastomas without
-catenin mutation (Eberhart et al., 2000). Consistenthowever, proteasome inhibition in PS/ cells did not
elevate P-45 after depletion of CK1 (Figure 4D), indicat- with previous observations, all primary medulloblasto-
mas examined with -catenin mutations contained nu-ing that lactacystin-induced increase in S45 phosphory-
lated -catenin after CK1 depletion in PS/ cells is clear -catenin to varying extent, although it was always
associated with extensive cytoplasmic staining (Figureattributable to presenilin activity. Taken together, these
results indicate that the effects of Axin/CK1 and pre- 5B). Similar to tumors derived from hPS1-rescued mice
described above, immunoreactivity for P-45 -cateninsenilin/PKA pathways on sequential phosphorylation of
-catenin represent independent and additive pathways. was essentially entirely nuclear in all four medulloblasto-
mas with these activating -catenin mutations but not
in those with wild-type -catenin (Figure 5B). As wasSelective Nuclear Accumulation of P-45 -Catenin
seen with total -catenin, not all cells were immunoreac-in PS1-Deficient Epidermal Tumors and in
tive for P-45 in the nucleus and the intensity was variableMedulloblastomas with Activating
where positive. These results indicate that Asp32- or-Catenin Mutations
Ser33-mutated -catenin is robustly phosphorylated atIncreasing evidence favors the hypothesis that an onco-
S45 and abnormally elevated in the nucleus of medullo-genic signal can originate from aberrant activation of
blastomas by failing to properly couple to the subse--catenin (Polakis, 2000). The preceding results showed
quent phosphorylation/ubiquitination steps, a phe-that presenilin deficiency results in stabilization of S45
notype mechanistically similar to tumors with PS1 defi-phosphorylated -catenin by failing to efficiently couple
ciency.the phosphorylation to residues 33/37/41. In this con-
text, our recent findings that PS1-deficient mice rescued
with human PS1 driven by the neuron-specific Thy-1 Hyperproliferative Phenotype in PS1 Null Spinal
Cord Resembling Ectopic Wnt-1 Expressionpromoter (hPS1 rescued mice) develop epidermal neo-
plasms take on greater importance (Xia et al., 2001). Dickinson and colleagues (1994) previously demon-
strated an in vivo phenotype resulting from aberrantAlthough PS1 null mice are embryonically lethal, hPS1
rescued mice are viable and survive into adulthood. Wnt/-catenin signaling in the developing embryo. In
that study, targeted overexpression of Wnt-1 inducedHowever, as the Thy-1 transgene is neuron specific,
hPS1 rescued mice lack PS1 in skin and develop epider- overgrowth of neural precursors in the developing spinal
cord, resulting in abnormally enlarged spinal cord,mal hyperplasias and carcinomas with over 90% pene-
trance in animals older than 9 months of age (Xia et asymmetric constriction of the ventricular zone, and
gross cellular disorganization. Because PS1 deficiencyal., 2001). Thus, we looked for the presence of P-45
-catenin in normal and abnormal epidermis from hPS1 is predicted to ectopically activate Wnt/-catenin sig-
naling, we looked for the presence of excessive Wntrescued mice by immunohistochemistry. Within the neo-
plastic tissue, strong total -catenin immunoreactivity signaling phenotype in the spinal cord of PS1/ em-
bryos. Compared to controls, embryonic PS1/ animalswas detected at the cell junctions and in the cytoplasm
and less frequently in the nucleus as previously reported indeed showed markedly enlarged spinal cords on
crosssectional diameter. Closer histological examina-(Xia et al., 2001). The amount of cytoplasmic -catenin
immunostaining relative to cell junction was substan- tion consistently showed higher number of cells with
distorted ventricular zone at embryonic day E15.5 (Fig-tially higher in neoplastic tissue than in either normal
adult skin or hyperplastic tissue (Figure 5A). Surprisingly, ure 6A). In addition, when the sections from PS1 null
animals were stained for cyclin D1, a downstream targetP-45 -catenin immunoreactivity was also found in epi-
dermal tumors from hPS1 rescued mice with almost of -catenin signaling and a marker of cell proliferation,
immunopositive cells (brown) were scattered through-exclusive nuclear localization (Figure 5A). In contrast,
nuclear immunoreactivity for P-45 -catenin was absent out the spinal cord at an age when cyclin D1-positive
cells are known to be absent (Figure 6B; Megason andin normal adult mouse skin tissues (Figure 5A). Impor-
tantly, in sections taken from epidermis of hPS1-rescued Mcmahon, 2002). To ascertain that PS1 deficiency re-
sulted in the expected -catenin stabilization and imbal-mice that demonstrated only hyperplasia without evi-
dence of malignancy, focal regions of intense nuclear ance of phosphorylated -catenin species, spinal cord
Presenilin-Dependent -Catenin Degradation
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Figure 5. Nuclear Localization of P-45
-Catenin in PS1-Deficient Epidermal Tu-
mors and in Human Medulloblastomas with
-Catenin Mutations
(A) Sections from epidermis of PS1-deficient
animals showing hyperplasia or tumor forma-
tion and control animals were immunostained
for P-45 and P-33/37/41 -catenin (brown)
and counterstained with hematoxylin (blue)
(original magnification 100).
(B) Tissue sections from human medulloblas-
tomas known to contain or lack-catenin mu-
tations were immunostained for total, P-45,
and P-33/37/41 -catenin (brown) and coun-
terstained with hematoxylin (blue). Note the
exclusive nuclear P-45 -catenin in the two
medulloblastomas with -catenin mutations
(D32A, S33F) despite extensively cytoplasmic
total -catenin (original magnification 100).
tissues from PS1/ embryos and control littermates this study was to define the mechanism of presenilin
regulation of -catenin turnover in hopes of providingrescued with human PS1 (PS1/; hPS1) were biochemi-
better insights into the in vivo phenotypes describedcally examined for levels of total and phosphorylated
previously in presenilin-deficient mice and in Drosoph--catenin. We found a 2-fold elevation in -catenin level
ila. The results showed that presenilin functions in ain PS1 null spinal cords (Figure 6B). This was accompa-
parallel and additive pathway to the Axin complex tonied by a marked reduction in the ratio of P-33/37/41
control -catenin degradation by facilitating the pairedper P-45 -catenin to 38% 10% of PS1 rescued spinal
phosphorylation steps of -catenin. These observationscords (n  4 each, Figure 6C), an in vivo confirmation
therefore provide a mechanistic basis for explainingthat PS1 deficiency impedes the paired phosphorylation
-catenin regulation through the presenilin complex,events. These results therefore argue that the loss of
findings that significantly extend the current canonicalPS1 in the CNS not only recapitulates the biochemical
model of -catenin turnover and presenilin biology.changes found in cultured cells but also leads to
In this study, we documented that presenilin defi-changes in the developing spinal cord that are highly
ciency reduces -catenin phosphorylation at residuesreminiscent of abnormal Wnt signaling.
33/37/41 relative to that phosphorylated at the S45, an
imbalance that was due to the impairment in linking
Discussion S45 phosphorylation to subsequent GSK-3-mediated
phosphorylation. Because S45 phosphorylation is re-
Presenilin-Dependent Control of -Catenin quired for the subsequent phosphorylation at 33/37/41
Phosphorylation and Degradation and ubiquitination, this finding not only provided the
In spite of the evidence supporting the negative regula- mechanistic explanation of the slowed rate of -catenin
tion of-catenin signaling by PS1, the molecular mecha- ubiquitination by the loss of presenilin (Soriano et al.,
2001), but also indicated that presenilin functions as annism responsible for this activity is unclear. The goal of
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Figure 6. PS1/ Embryos Display Hyper-
proliferative Spinal Cord Phenotype Resem-
bling Ectopic Wnt-1 Overexpression
(A) Enlargement, disorganization, and hyper-
proliferation of PS1 null spinal cord at embry-
onic day E15.5. Upper panels: normal histol-
ogy from thoracic sections showing central
canal (cc), ventral and dorsal horns (vh, dh),
and marginal zone (mz) in PS1/ spinal cord,
but enlargement and cellular disorganization
were apparent in PS1/ spinal cords (original
magnification 4 stained with hematoxylin).
Lower panels: sections from PS1/ and
PS1/ littermates immunostained for cyclin
D1 with DAB (brown) and counterstained with
hematoxylin (blue). Cyclin D1 was abundant
in nucleus and cytosol of a significant propor-
tion of cells in PS1 null (red arrowheads) but
not in PS1/ spinal cords (original magnifica-
tion 20).
(B) Increased total -catenin in E15.5 PS1 null
spinal cords as compared to PS1/ rescued
with human PS1 by immunoblotting.
(C) Reduced levels of P-33/37/41 per P-45
-catenin in E15.5 PS1 null spinal cords. Spi-
nal cord extracts from PS1/ and PS1/
(hPS1) littermates were immunoblotted for
P-33/37/41 and P-45 -catenin. Graphs rep-
resent the percentage amount of P-33/37/41
per P-45 -catenin in PS1/ samples relative
to PS1-expressing controls (n 4 standard
deviation).
intermediate between S45 and 33/37/41 phosphoryla- bridging the two phosphorylation events. Thus, S45
phosphorylation of -catenin outside of either Axin ortion events. Two models of presenilin action can explain
these findings (Figure 7). In the first scenario, presenilin presenilin complexes appear to decouple the subse-
quent 33/37/41 phosphorylation, resulting in accumula-sequesters -catenin already phosphorylated at S45,
perhaps a pool that has escaped the Axin complex, for tion of both total and P-45 -catenin together with a
disproportionate reduction in P-33/37/41.subsequent phosphorylation at 33/37/41 by GSK-3.
Second, presenilin functions as a scaffold connecting Based on the current results, we propose a model in
which presenilin functions in parallel to the Axin complexa priming kinase pathway with GSK-3 activity within
the same complex, much as that proposed for Axin (Liu and independent of the Wnt-regulated pathway (Figure
7). Several lines of evidence support this conclusion.et al., 2002). The latter scenario is supported by our
observation that the presenilin complex together with First, inactivation of the Axin complex by Wnt-3a did
not abrogate the presenilin activity on -catenin phos-the PKA pathway was not only capable of S45 phosphor-
ylation in vitro and in vivo but also robustly facilitated phorylation, consistent with previous documentation
that PS1 overexpression decreased Wnt-induced stabi-GSK-3-dependent 33/37/41 phosphorylation, a mech-
anism in concordance with the priming kinase model of lization of -catenin and nuclear signaling (Killick et al.,
2001). Second, stable overexpression of PS1 led to a-catenin phosphorylation. However, it is notable that
loss of presenilin does not preclude the priming step. reduction in -catenin even in Axin-deficient cells. Third,
CK1/Axin activity on S45 -catenin phosphorylationSimilarly, we observed that Axin deficiency in SNU475
cells did not impair S45 phosphorylation but resulted in was independent of presenilin. Fourth, presenilin activity
on S45 phosphorylation was insensitive to CK1/Axina marked reduction in P-33/37/41 -catenin (data not
shown), suggesting that scaffolding proteins are not re- expression, a result consistent with the proposal that
the PKA pathway may represent a second S45 primingquired for the initial priming event but are needed for
Presenilin-Dependent -Catenin Degradation
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Figure 7. Schematic Model of P-45 and P-33/
37/41 -Catenin Degradation and Signaling
Pathways
-catenin is sequentially phosphorylated at
S45, then at 33/37/41 by two parallel and in-
dependent pathways, Axin/CK1/GSK-3
and presenilin/PKA/GSK-3. However, only
the former canonical pathway is responsive
to Wnt stimulation.
mechanism working in conjunction with presenilin. In- tensive nuclear localization of P-45 -catenin, indicating
a severe impairment in the subsequent phosphorylation/deed, similar priming events have previously been docu-
mented for CREB and cubitus interruptus, where PKA degradation steps. Notably, P-45 -catenin reactivity
was elevated not only in the neoplastic tissue but oftenactivity is required for subsequent GSK-3-mediated
phosphorylation (Fiol et al., 1994; Price and Kalderon, also in regions that were hyperplastic or histologically
normal in PS1-deficient skin. Thus, abnormal activation2002). Taken together, these results indicate that pre-
senilin-dependent sequential phosphorylation and deg- of -catenin signaling not only antedates neoplastic
transformation of epidermal tissue lacking PS1 but alsoradation of -catenin is independent of Axin/CK1 and
not regulated by the Wnt pathway. strongly supports the postulate that activated -catenin
signaling can be an initiating event in the progressionBecause the loss of presenilin resulted in the elevation
of -catenin level even when the Axin/CK1 complex is to neoplastic transformation. This notion is supported
by the formation of adnexal tumors in transgenic micefunctional, the Axin complex is apparently not able to
process all pools of -catenin for degradation. Whether with targeted expression of an N-terminally truncated
-catenin, a mutant that bypasses regulation by boththis is due to the segregation of Axin and presenilin to
cytosolic and membrane compartment, respectively, is Axin and presenilin complexes (Gat et al., 1998). Further-
more, we have detected malignancies in skin and otherpresently unclear. Nevertheless, there is evidence to
suggest that the level of Axin expression is physiologi- organs in mice deficient in PS2 and hemizygous for PS1
deficiency (unpublished observations), suggesting thatcally constrained. For example, Axin overexpression
leads to cell death, thereby precluding selection of sta- presenilin-dependent regulation of -catenin turnover
and tumorigenesis is a dose-dependent phenomenon.ble transfectants overexpressing Axin (Neo et al., 2000).
We also found that stable expression of Axin greater In this study, we also examined other organs in PS1-
deficient mice to corroborate evidence of -catenin dys-than 2-fold above endogenous levels was not possible
in either PS/ or PS/ cells. Because Axin but not regulation and signaling in vivo. Taking advantage of
reduced P-33/37/41 levels per P-45 -catenin as a “sig-presenilin activity is a target of the Wnt pathway, we
hypothesize that presenilin activity takes on greater sig- nature” of presenilin inactivity, we confirmed this bio-
chemical phenotype in vivo in spinal cords of late gesta-nificance when the Axin complex is not fully functional,
in particular because Wnt signaling not only inactivates tion PS1/ embryos. Moreover, loss of PS1 led to
Axin but also induces its degradation (Yamamoto et cellular overgrowth and disorganization of the develop-
al., 1999). Thus, a secondary Wnt-independent complex ing spinal cord, a morphological phenotype precisely
may be necessary to compensate for the reduction in resembling that described with targeted Wnt-1 overex-
both Axin protein level and activity that occur upon ces- pression in the spinal cord. This phenotype is not attrib-
sation of the physiological Wnt signal. In this way, pre- utable to impaired intramembrane proteolysis of Notch
senilin activity may be particularly important in adult receptor and hence reduced Notch signaling, because
tissues that are subjected to continuous cycles of Wnt ectopic activation rather than loss of Notch signaling in
signaling. the spinal cord leads to expansion of neural precursors
(Lardelli et al., 1996). Taken together, these observations
of hyperproliferation in embryonic spinal cord and hy-Loss of PS1 and Abnormal -Catenin
perplasia and tumorigenesis in epidermis provide furtherSignaling In Vivo
evidence that the presenilins play an important physio-The rapid proteolysis of cytosolic -catenin is such that
logical role in the regulation of -catenin turnover andconstitutive nuclear localization of -catenin is a marker
normal physiology during embryogenesis and postnatalfor activation of -catenin signaling and can be detected
development. Importantly, our studies show that it isin tumors containing APC, Axin, and-catenin mutations
essential to take into account the dual parallel Axin and(reviewed by Polakis, 2000). Immunohistochemical ex-
presenilin pathways when examining the regulation ofamination of tumors with either PS1 deficiency or acti-
vating -catenin mutations (D32 and S33) revealed ex- -catenin degradation and signaling.
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clonal selection. L cells stably transfected with Wnt-3a have pre-Presenilin Action and Possible Relevance
viously been described (Shibamoto et al., 1998) and were used asto Alzheimer’s Disease
a source of Wnt3a CM. To transfect CK1 RNAi, PS/ and PS/In this study, we demonstrated that presenilin-depen-
cells were incubated with either sense RNA or CK1 RNAi duplex
dent -secretase activity is separable from presenilin- together with oligofectamine (Invitrogen) for 48 hr with sequences
dependent P-45 -catenin turnover, since the D257A previously documented (Liu et al., 2002).
PS1 mutant that is defective in Notch and APP proteoly-
Cell Lysis and Tissue Homogenizationsis contained full activity in restoring the turnover of
Cells were lysed in 1% 3-[(3-cholamidopropyl) dimethylammonio]-P-45 -catenin in PS/ cells, and pharmacological
2-hydroxy-1-propanesulfonate (CHAPS) lysis buffer containing 50-secretase inhibition did not interfere with turnover of
mM Tris (pH 8.0), 150 mM NaCl, 0.02% sodium azide, 400 nM Micro-P-45 -catenin. Furthermore, treatment of the PS1 im-
cystin-LR, 0.5 mM sodium vanadate, and 1 Protease Inhibitor
mune complex with -secretase inhibitor had no effect cocktail (Roche). Spinal cords and brains from PS1/ and PS1/
on the ability of the PS1 complex to mediate phosphory- mice rescued with human PS1 driven by the Thy-1 promoter [PS1/
(hPS1)] were homogenized by 60 strokes in a micro-dounce homog-lation of S45 and 33/37/41 of GST--catenin (data not
enizer in CSK buffer (0.5% triton X-100, 50 mM NaCl, 10 mM HEPESshown). These new observations reinforce our hypothe-
[pH 6.8], 3 mM MgCl2, 300 mM sucrose, complete protease inhibitorsis that presenilin-mediated intramembrane proteolysis
cocktail [Roche], and phosphatase inhibitors). From the CSK solubleand primed sequential phosphorylation of -catenin are
fraction, Concanavalin-A bound material was removed, and the re-
mutually exclusive parallel functions, possibly requiring maining fraction was used for immunoblotting. Protein concentra-
different presenilin conformations. An important impli- tions were measured by the micro-BCA method (Pierce). Quantita-
tions were performed by a CCD camera-based imaging systemcation of these results is that selective -secretase inhi-
(GeneGnome, Syngene).bition is possible without perturbing -catenin turnover.
Although the current observations are not directly perti-
-Catenin Turnover Assaysnent to AD, it is possible that aberrant biological activi-
Overnight cultures at near confluency (90%–100%) were treated
ties of the presenilin complex unrelated to amyloid with 25 g/ml cycloheximide for the indicated times, and CHAPS
-protein production can influence the neurodegenera- lysates were subjected to immunoblotting by phospho-specific
tive process. In particular, the presence of at least two -catenin antibodies and enhanced chemiluminescence (Pierce).
Quantitations were performed by a CCD camera-based imagingkinase activities within the PS1 complex may be related
system (GeneGnome, Syngene) or by phosphorimaging (BioRad).to AD pathogenesis, as abnormal hyperphosphorylation
All experiments were performed at least three times, and resultsof tau and -synuclein are pathological features of AD
from either a representative experiment or averagesSE are shown.
(Bierer et al., 1990; Fujiwara et al., 2002). Because both
PKA and GSK-3 pathways are considered to be impor- Immunohistochemistry
tant contributors for tau hyperphosphorylation (Ishiguro Paraffin-embedded skin samples were from wild-type and hPS1-
et al., 1992; Jicha et al., 1999), it is possible that preseni- rescued adult mice (12 months old) as previously described (Xia et
al., 2001). Medulloblastoma samples were formalin fixed and em-lin activity may modify tangle pathology through as yet
bedded in paraffin as previously described (Eberhart et al., 2000).unknown mechanisms.
PS1/ and PS1/ embryos from embryonic day E15.5 were fixed
and embedded in paraffin. Deparaffinized sections (5 m) were im-Experimental Procedures
munostained overnight at 4C with the indicated antibodies, de-
tected with the Vectastain Universal ABC kit (Vector Laboratories)Antibodies and Reagents
using DAB as the chromogen, and counterstained with hematoxylin.The polyclonal antibody J27 (against residues 27–42 of PS1) and
the monoclonal antibody PSN2 (against residues 31–56 of PS1) have
In Vitro Phosphorylation Assayspreviously been described (Zhang et al., 1998). Monoclonal antibod-
Confluent cultures of PS/ (hPS1), PS/, or PS/ (hPS1) cells wereies against the C terminus of -catenin (BD Laboratories), catalytic
lysed in 1% CHAPS buffer and cleared by centrifugation, and thesubunit of PKA (BD Laboratories), GSK-3 (BD Laboratories), multi-
supernatant precleared with either Protein-A agarose with normalubiquitin (MBL, Nagoya, Japan), -tubulin (Amersham Pharmacia
rabbit serum or anti-mouse IgG agarose beads. For in vitro phos-Biotech), cyclin D1 (Calbiochem), affinity-purified polyclonal anti-
phorylation of GST--catenin by PS1 immune complexes by [-32P]ATPbodies against 33/37/41 and 41/45 phospho--catenin (Cell Signal-
incorporation, J27 immune or preimmune precipitates were incubateding), forskolin (Calbiochem), H89 (Calbiochem), CK1-7 (Seikagaku,
with 5 ng of purified recombinant GST--catenin in kinase buffer (50Japan), and purified GSK-3 and PKA (Cell Signaling) were obtained
mM Tris [pH 8], 30 mM MgCl2, 3 mM EGTA, and protease andfrom commercial sources.
phosphatase inhibitors) in the presence of [-32P]ATP for 30 min at
30C, after which the proteins were fractionated on SDS-PAGE andcDNA Constructs
the dried gels were exposed to film. For in vitro phosphorylation ofThe cDNAs encoding wild-type PS1, PS1
cat, and PS1 D257A were
GST--catenin by PS1 immune complexes or by purified GSK-3 orsubcloned into pBabe-puro and transfected into GPE-86 packag-
PKA for detection of P-45 and P-33/37/41 -catenin, PSN2 immuneing cell line as previously described (Soriano et al., 2001). To gener-
precipitates or purified enzymes were incubated with 40 ng of re-ate glutathione S-transferase (GST)-tagged -catenin fusion protein,
combinant GST--catenin in kinase buffer (50 mM HEPES [pH 7.4],wild-type mouse -catenin (Barth et al., 1997) was subcloned into
20 mM MgCl2, 5 mM DTT, and protease and phosphatase inhibitors)pGEX4T-1 plasmid and purified from bacteria using glutathione aga-
in the presence of 200 M ATP for the indicated times at 30C, afterrose beads in accordance with the manufacturer’s instructions
which the proteins were fractionated on SDS-PAGE and probed for(Pharmacia).
either P-45 or P-33/37/41 -catenin. In experiments comparing GSK-
3 activity alone with PS1/GSK-3 activity, phosphorylation reac-Cell Lines and Transfections
tions included anti-mouse IgG beads.All cell lines were grown in DMEM containing 10% FBS. Immortalized
PS/ and PS/ (genetically deficient in PS1 and PS2) cells have
been described previously (Herreman et al., 2000). To introduce PS1 Acknowledgments
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